tak-788
Showing 1 - 7 of 7
NSCLC Trial in Japan (TAK-788)
Active, not recruiting
- Non-Small Cell Lung Cancer
- TAK-788
-
Nagoya, Aichi, Japan
- +24 more
Jul 12, 2022
NSCLC, Lung Tumors Trial in Australia, Netherlands, Singapore (Midazolam, TAK-788)
Completed
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms
- Midazolam
- TAK-788
-
St Leonards, New South Wales, Australia
- +7 more
Feb 14, 2022
NSCLC Trial in Worldwide (TAK-788)
Recruiting
- Carcinoma, Non-Small-Cell Lung
- TAK-788
-
Birmingham, Alabama
- +56 more
Jan 23, 2023
NSCLC (NSCLC) Trial (TAK-788, Antidiarrheal prophylaxis)
Withdrawn
- Non-Small Cell Lung Cancer (NSCLC)
- TAK-788
- Antidiarrheal prophylaxis
- (no location specified)
Dec 15, 2020
Healthy Volunteers Trial in Salt Lake City (TAK-788, Placebo)
Completed
- Healthy Volunteers
- TAK-788
- Placebo
-
Salt Lake City, UtahPRA Health Sciences
Jan 16, 2020